# AI_MODEL_CHANGE_CONTROL.md  
**AI Model Change Control & Lifecycle Governance Framework**

---

## 1. Purpose

This document establishes the **AI Model Change Control Framework** for NeuroGrid systems.  
Its purpose is to ensure that any modification to AI models—whether architectural, data-driven, or operational—is **controlled, auditable, ethically reviewed, and regulator-aligned**.

AI models used within NeuroGrid may influence clinical interpretation, monitoring prioritization, or decision support. Therefore, **uncontrolled change is prohibited**.

---

## 2. Scope

This framework applies to:

- Machine learning models
- Statistical inference models
- Signal processing models
- Clinical decision-support algorithms
- Any AI component influencing RPM, diagnostics, or research outcomes

It covers **pre-deployment, post-deployment, and emergency changes**.

---

## 3. Regulatory & Standards Alignment

This change control framework aligns with:

- EU MDR (Annex IX, Article 10)
- FDA Software Change Guidance
- ISO 13485 (Design Control)
- ISO 14971 (Risk Management)
- IEC 62304 (Software Lifecycle)
- OECD AI Principles
- WHO Guidance on AI in Healthcare

---

## 4. Model Change Categories

All AI model changes are classified into one of the following categories:

### 4.1 Type I — Minor Change
Examples:
- Hyperparameter tuning
- Performance optimization without output logic change
- Infrastructure-only adjustments

Impact:
- No clinical behavior change

Approval:
- Technical review only

---

### 4.2 Type II — Moderate Change
Examples:
- Dataset expansion
- Feature engineering updates
- Threshold recalibration
- Model retraining with same architecture

Impact:
- Potential output behavior variation

Approval:
- Technical + Ethics review
- Performance validation required

---

### 4.3 Type III — Major Change
Examples:
- New model architecture
- New clinical task
- Expanded clinical use claims
- Introduction of autonomous elements

Impact:
- Material clinical or ethical implications

Approval:
- Full governance approval
- Risk reassessment
- Regulatory notification (if applicable)

---

## 5. Change Control Principles

All AI model changes must adhere to:

- **Traceability** – clear link to rationale and impact
- **Reproducibility** – deterministic training records
- **Explainability** – documented behavior shifts
- **Reversibility** – rollback capability
- **Human Oversight** – no unsupervised deployment

---

## 6. Change Request Process

Each change must be initiated through a **Model Change Request (MCR)** including:

- Change description
- Rationale
- Affected systems
- Risk assessment
- Validation plan
- Rollback strategy

No model may be altered without an approved MCR.

---

## 7. Validation & Testing Requirements

Before deployment, changes must undergo:

- Performance benchmarking
- Bias and fairness analysis
- Stress and edge-case testing
- Comparison against baseline model
- Clinical simulation (where applicable)

Validation artifacts must be archived.

---

## 8. Ethics Review Requirements

Any model change that:

- Alters clinical interpretation
- Affects patient prioritization
- Modifies alert behavior
- Expands data usage

**Requires ethics committee review** prior to deployment.

Ethics approval must be explicitly recorded.

---

## 9. Deployment Controls

Approved changes must be deployed using:

- Versioned model identifiers
- Canary or phased rollout (where feasible)
- Monitoring hooks for early anomaly detection

Emergency rollbacks must be executable within predefined timelines.

---

## 10. Post-Deployment Monitoring

After deployment, the model is subject to:

- Drift monitoring
- Performance surveillance
- Adverse event correlation
- Real-world outcome tracking

Post-deployment metrics are reviewed within defined intervals.

---

## 11. Documentation & Auditability

For each model version, NeuroGrid maintains:

- Training datasets (hashed references)
- Model artifacts
- Validation reports
- Approval records
- Deployment timestamps

All documentation must be audit-ready.

---

## 12. Governance & Accountability

### 12.1 Oversight Authority
- Model Governance Committee (technical + clinical + ethics)

### 12.2 DAO Role
- Approves major model changes
- Ensures transparency
- Maintains immutable decision logs

### 12.3 Contributors
- Must disclose conflicts of interest
- Are accountable for submitted changes

---

## 13. Prohibited Practices

The following are explicitly prohibited:

- Silent model updates
- Shadow deployments
- Training on unapproved datasets
- Changes without rollback plans
- Autonomous clinical decision-making without human oversight

---

## 14. Continuous Improvement

Insights from:

- Post-market surveillance
- Ethics reviews
- Adverse event analysis

Feed back into model governance refinement.

---

## 15. Review Cycle

This document is reviewed:

- Annually
- After major incidents
- Upon regulatory changes
- After significant AI capability expansion

---

## 16. Foundational Statement

> **In medicine, change is power.  
> Power without control is harm.**

---

### Status
**AI Model Change Control – Active Governance Document**  
Applies to all NeuroGrid AI-enabled systems.

